(Circulation. 1999;99:338-339.)
© 1999 American Heart Association, Inc.
Editorial |
From the Emory University School of Medicine, Atlanta, Ga.
Correspondence to Robert C. Schlant, MD, Professor of Medicine (Cardiology), Emory University School of Medicine, 69 Butler St, SE, Atlanta, GA 30303.
Key Words: Editorials surgery mitral valve regurgitation
Amajor problem in the management of patients with chronic, severe mitral regurgitation (MR) remains the timing of operative intervention. This is particularly true for patients with nonischemic severe MR, which in the United States is now most often due to mitral valve prolapse, frequently with a flail mitral leaflet. Surprisingly, some patients with this condition do not have undue fatigue or dyspnea during ordinary physical activity and therefore are in NYHA functional class I.1 Patients are classified as functional class II when they have slight limitation of physical activity and are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. Patients are classified as functional class III when they have cardiac disease that results in marked limitation of physical activity; although patients in functional class III are comfortable at rest, less-than-ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain. Patients are classified as functional class IV when their cardiac disease results in inability to carry on any physical activity without discomfort. Symptoms of heart failure or of the anginal syndrome may be present even at rest and may increase if any physical activity is undertaken.
It is significant that this functional classification is based
entirely on subjective symptoms. This was one of the reasons why this
functional classification described in the sixth edition (1964) was
replaced in the seventh (1973) and eighth (1979) editions of the NYHA
Nomenclature and Criteria for Diagnosis of Diseases of the Heart
and Great Vessels. The most recent
This article has been cited by other articles:
![]() |
K. Bando, H. Kasegawa, Y. Okada, J. Kobayashi, A. Kada, T. Shimokawa, M. Nasu, S. Nakatani, K. Niwaya, O. Tagusari, et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Haan, C. I. Cabral, D. A. Conetta, L. P. Coombs, and F. H. Edwards Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery Ann. Thorac. Surg., September 1, 2004; 78(3): 820 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Iung, C. Gohlke-Barwolf, P. Tornos, C. Tribouilloy, R. Hall, E. Butchart, and A. Vahanian Recommendations on the management of the asymptomatic patient with valvular heart disease Eur. Heart J., August 2, 2002; 23(16): 1253 - 1266. [PDF] |
||||
![]() |
E. Lim, C. W. Barlow, A. R. Hosseinpour, C. Wisbey, K. Wilson, W. Pidgeon, S. Charman, J. B. Barlow, and F. C. Wells Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Circulation, September 18, 2001; 104 (2009): I-59 - I-63. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |